Showing 171-180 of 5382 results for "".
JAK Inhibitors in Hidradenitis Suppurativa: A Systematic Review
https://practicaldermatology.com/topics/feature/jak-inhibitors-in-hidradenitis-suppurativa-a-systematic-review/29887/Hidradenitis suppurativa (HS) is a chronic, disfiguring, debilitating, inflammatory disorder that is characterized by inflammatory nodules, abscesses, fistulae/ sinus tracts, and scarring to the axilla, inframammary folds, and groin.FDA Approves Bimzelx for Hidradenitis Suppurativa
https://practicaldermatology.com/series/dermwire-tv/fda-approves-bimzelx-hidradenitis-suppurativa/29518/In this week's DermwireTV, the FDA approves a new treatment for moderate to severe hidradenitis suppurativa; the FDA agrees to review the resubmission of Dupixent for the treatment of CSU; and the president of Merz Aesthetics, North America, joins us to discuss trends in the aesthetic market.SDPA: Medical Director Dr. Hilary Baldwin Discusses Acne and Keloids Lectures
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-discusses-acne-and-keloids-lectures/29508/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. She explains the key takeaways of her lectures on acne and keloids.How to Recognize Physician Burnout
https://practicaldermatology.com/series/pa-perspectives/how-recognize-physician-burnout/29206/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses how to recognize physician burnout, and the importance of strategically adding breaks in your monthly schedule.How to Approach a Contract Negotiation
https://practicaldermatology.com/series/pa-perspectives/how-approach-contract-negotiation/29072/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, provides tips on how to approach a contract negotiation, including the importance of using objective data while negotiating.Dr. Hartman Discusses the Importance of Skin of Color Update
https://practicaldermatology.com/topics/skin-of-color/dr-hartman-discusses-the-importance-of-skin-of-color-update/28656/Corey L. Hartman, MD, FAAD, Founder of Skin Wellness Dermatology and YoungMD Connect Advisor, shares insights and key takeaways he looks forward to at the Skin of Color Update.Hair Regrowth and Choosing Your Device
https://practicaldermatology.com/series/pdt-in-practice/hair-regrowth-and-choosing-your-device/26994/Dr. Hamza D. Bhatti, a board-certified dermatologist and dually accredited fellowship-trained Mohs micrographic surgeon and cosmetic dermatologic surgeon, discusses utilizing red light photodynamic therapy (PDT) for hair regrowth with androgenic alopecia, as well as key considerations when selectingDisseminated Varicella Zoster Virus and Herpes Zoster Virus Infection in a Pediatric Patient with Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/disseminated-varicella-zoster-virus-herpes-zoster-pediatric-atopic-dermatitis/24464/Sarah N. Rimmer, MD, Nicholas Culotta, MD, and India Hill, MD take readers through a case highlighting need what they see as a need to understand dupilumab’s dose-dependent modulation of pediatric immune systems.Pigmentation: Melasma vs. Postinflammatory Hyperpigmentation
https://practicaldermatology.com/conferences/maui-derm-2024/pigmentation-melasma-vs-hyperpigmentation-vitiligo-treatments-and-full-spectrum-photo-protection/20247/Chief Medical Editor Neal Bhatia, MD and Pearl Grimes, MD, discuss Dr. Grimes’ presentations on pigmentation, including the difference between melasma and postinflammatory hyperpigmentation, and the importance of photo-protection in darker skin types.How New Molluscum Contagiosum Treatments Will Boost QoL and Limit Infection
https://practicaldermatology.com/topics/pediatric/how-new-molluscum-contagiosum-treatments-will-boost-qol-and-limit-infection/20244/Adam Friedman, MD, George Washington School of Medicine discusses the first FDA-approved nitric-oxide based drug in dermatology plus other recent approvals that he believes will make patients lives much easier and reduce the continuity of this condition.